Prevalence and clinical features of chronic uveitis in pediatric inflammatory bowel diseases: A nationwide study.

Crohn's disease Extraintestinal manifestations inflammatory bowel diseases (IBD) ulcerative colitis

Journal

Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545

Informations de publication

Date de publication:
09 Apr 2024
Historique:
revised: 12 03 2024
received: 31 01 2024
accepted: 03 04 2024
medline: 10 4 2024
pubmed: 10 4 2024
entrez: 10 4 2024
Statut: aheadofprint

Résumé

Inflammatory bowel diseases (IBD) encompass a group of chronic inflammatory disorders primarily affecting the gastrointestinal tract but capable of impacting various organs, including the eye, with uveitis being the most common ocular condition. We assessed uveitis prevalence and clinical features in a nationwide cohort of pediatric IBD. Among 4229 cases, six patients (four Crohn's disease, one ulcerative colitis, and one unclassified IBD) were identified, resulting in an overall prevalence rate of 141.8 per 100,000 patients. Uveitis onset varied: two before IBD, two after, and two concomitantly. Symptomatic uveitis occurred in 2/6 patients, with anterior involvement in all cases. Median follow-up was 3 years (interquartile range [IQR]: 2-4.75 years). At the last follow-up, 5/6 patients exhibited quiescent IBD, while 4/6 had inactive uveitis. One patient had ocular complications. Uveitis is a rare but potentially complicating manifestation of pediatric IBD.

Identifiants

pubmed: 38594804
doi: 10.1002/jpn3.12216
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : None

Informations de copyright

© 2024 European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Références

Alvisi P, Labriola F, Scarallo L, et al. Epidemiological trends of pediatric IBD in Italy: a 10‐year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry. Dig Liver Dis. 2022;54:S1590865822000019. doi:10.1016/j.dld.2021.12.018
Scarallo L, Griffiths AM. Medical therapy of paediatric inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2022;19:685‐686. doi:10.1038/s41575-022-00686-8
Greuter T, Bertoldo F, Rechner R, et al. Extraintestinal manifestations of pediatric inflammatory bowel disease: prevalence, presentation, and Anti‐TNF treatment. J Pediatr Gastroenterol Nutr. 2017;65:200‐206. doi:10.1097/MPG.0000000000001455
Dotson JL, Hyams JS, Markowitz J, et al. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J Pediatr Gastroenterol Nutr. 2010;51:140‐145. doi:10.1097/MPG.0b013e3181ca4db4
Ottaviano G, Salvatore S, Salvatoni A, Martelossi S, Ventura A, Naviglio S. Ocular manifestations of paediatric inflammatory bowel disease: a systematic review and meta‐analysis. J Crohns Colitis. 2018;12:870‐879. doi:10.1093/ecco-jcc/jjy029
Jose FA, Garnett EA, Vittinghoff E, et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:63‐68. doi:10.1002/ibd.20604
Rohani P, Abdollah Gorji F, Eshaghi M, Javadi Parvaneh V, Moradi M, Zojaji R. Ocular complications of pediatric inflammatory bowel disease: a case series from a pediatric tertiary medical center. Clin Pediatr. 2022;61:347‐351. doi:10.1177/00099228221078105
Aloi M, Lionetti P, Barabino A, et al. Phenotype and disease course of early‐onset pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:597‐605. doi:10.1097/01.MIB.0000442921.77945.09
Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. results of the first international workshop. Am J Ophthalmol. 2005;140(3):509‐516. doi:10.1016/j.ajo.2005.03.057
Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314‐1321. doi:10.1002/ibd.21493
Maccora I, Marrani E, Pagnini I, et al. Challenges and management of childhood noninfectious chronic uveitis. Expert Rev Clin Immunol. 2023;19:599‐611. doi:10.1080/1744666X.2023.2198210
Angeles‐Han ST, Ringold S, Beukelman T, et al. 2019 American college of Rheumatology/Arthritis foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis–associated uveitis. Arthritis Care Res. 2019;71:703‐716. doi:10.1002/acr.23871.

Auteurs

Valerio Maniscalco (V)

Rheumatology Unit, ERN-ReCONNET Center, Meyer Children Hospital IRCCS, Florence, Italy.

Luca Scarallo (L)

Gastroenterology and Nutrition Unit, Meyer Children Hospital IRCCS, Florence, Italy.
NEUROFARBA Department, University of Florence, Florence, Italy.

Marina Aloi (M)

Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Rome, Italy.

Patrizia Alvisi (P)

Pediatric Gastroenterology Unit, Pediatrics Department, Maggiore C.A. Pizzardi Hospital, Bologna, Italy.

Lorenzo Norsa (L)

Pediatric Hepatology Gastroenterology and Transplantation Unit ASST Papa Giovanni XXIII, Bergamo, Italy.
Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.

Giovanna Zuin (G)

Department of Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.

Gabriele Simonini (G)

Rheumatology Unit, ERN-ReCONNET Center, Meyer Children Hospital IRCCS, Florence, Italy.
NEUROFARBA Department, University of Florence, Florence, Italy.

Paolo Lionetti (P)

Gastroenterology and Nutrition Unit, Meyer Children Hospital IRCCS, Florence, Italy.
NEUROFARBA Department, University of Florence, Florence, Italy.

Classifications MeSH